Page 3 - Clinical Testing News Today

A report by University of Queensland researchers has warned a global crisis of antibiotic resistance is inevitable, despite promising developments in new antibiotics.

CEPI, the Coalition for Epidemic Preparedness Innovations, and the Houston Methodist Research Institute (HMRI), have today announced a partnership to combine cutting-edge artificial intelligence (AI) technology with established laboratory techniques to speed up development of future vaccines against novel viral threats (also known as Disease X).

The Association for Molecular Pathology (AMP), the premier global molecular diagnostic professional society, today published consensus recommendations to aid in the design and validation of clinical CYP3A4 and CYP3A5 genotyping assays, promote standardization of testing across different laboratories, and improve patient care.

CBL-514 is the only non-invasive product that can improve 1-level of cellulite severity two weeks after a single treatment. The highest dose of CBL-514...

The "Automated and Rapid Microbiological Tests: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.

The two unrelated clinical trials were put on hold after six participants, including one child, died while testing new cancer drugs.

Trends, opportunity and forecast in the global exosome research market to 2028 by product & service (kits & reagents, instruments, and services),...

Chimeric Therapeutics Ltd (ASX:CHM) has made headway on multiple fronts in the past quarter, with material progress visible in its pipeline candidates,...

Researchers designed surveillance programs for the early detection of patients at elevated risk of pancreatic cancer.

Dublin, April 20, 2023 (GLOBE NEWSWIRE) -- The "Latin American Flow Cytometry Market by Technology (Cell-based, Bead-based), Product & Service...